Influence of immune checkpoint inhibitor target and timing on combination treatment with antibody-based β-emitting targeted radionuclide therapy across tumor immunogenicity profiles
- DOI
- 10.3389/fimmu.2026.1872928
- Published
- 2026-08-04
- Container
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1872928,
title = {Influence of immune checkpoint inhibitor target and timing on combination treatment with antibody-based β-emitting targeted radionuclide therapy across tumor immunogenicity profiles},
author = {Simone C. Kleinendorst and Egbert Oosterwijk and Mark Konijnenberg and Milou Boswinkel and Manon Gloudemans and Sylvia T.M. Wenker and Stijn Muselaers and Peter Mulders and Lyndsey Maffa and Michael F. O’Hara and Michael P. Wheatcroft and Kwame Twumasi-Boateng and Sandra Heskamp},
year = {2026},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2026.1872928},
url = {https://doi.org/10.3389/fimmu.2026.1872928}
}RIS
TY - JOUR TI - Influence of immune checkpoint inhibitor target and timing on combination treatment with antibody-based β-emitting targeted radionuclide therapy across tumor immunogenicity profiles AU - Simone C. Kleinendorst AU - Egbert Oosterwijk AU - Mark Konijnenberg AU - Milou Boswinkel AU - Manon Gloudemans AU - Sylvia T.M. Wenker AU - Stijn Muselaers AU - Peter Mulders AU - Lyndsey Maffa AU - Michael F. O’Hara AU - Michael P. Wheatcroft AU - Kwame Twumasi-Boateng AU - Sandra Heskamp PY - 2026 JO - Frontiers in Immunology DO - 10.3389/fimmu.2026.1872928 UR - https://doi.org/10.3389/fimmu.2026.1872928 ER -
APA
Kleinendorst, S. C., Oosterwijk, E., Konijnenberg, M., Boswinkel, M., Gloudemans, M., Wenker, S. T., Muselaers, S., Mulders, P., Maffa, L., O’Hara, M. F., Wheatcroft, M. P., Twumasi-Boateng, K., & Heskamp, S. (2026). Influence of immune checkpoint inhibitor target and timing on combination treatment with antibody-based β-emitting targeted radionuclide therapy across tumor immunogenicity profiles. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1872928
Source records
- crossref · retrieved 2026-09-27T01:30:24.499Z